Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

125 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Is there an association between high heparanase level and osteoporosis risk in breast cancer patients without clinical evidence of bone metastases?
Altundag K, Altundag O, Baptista MZ, Turen S, Atik MA. Altundag K, et al. Among authors: altundag o. Osteoporos Int. 2005 Dec;16(12):2195-6. doi: 10.1007/s00198-005-2034-x. Osteoporos Int. 2005. PMID: 16273325 No abstract available.
Heparanase activity and bone loss in postmenopausal breast cancer patients.
Altundag K, Altundag O, Baptista MZ, Akyurek S. Altundag K, et al. Among authors: altundag o. J Clin Oncol. 2005 Dec 1;23(34):8916-7; author reply 8917-8. doi: 10.1200/JCO.2005.04.0121. J Clin Oncol. 2005. PMID: 16314656 No abstract available.
Tobacco smoking and breast cancer.
Baptista MZ, Altundag K, Akyurek S, Altundag O. Baptista MZ, et al. Among authors: altundag o, altundag k. Breast J. 2006 Jul-Aug;12(4):396-7. doi: 10.1111/j.1075-122X.2006.00291.x. Breast J. 2006. PMID: 16848862 No abstract available.
Late local recurrences in a randomized trial comparing conservative treatment with total mastectomy in early breast cancer patients: the impact of receptor status on local relapse.
Altundag O, Altundag K, Altundag M. Altundag O, et al. Among authors: altundag m, altundag k. Ann Oncol. 2004 Jun;15(6):990; author reply 991. doi: 10.1093/annonc/mdh237. Ann Oncol. 2004. PMID: 15151962 No abstract available.
Free circulating DNA: good as a diagnostic marker in lung cancer?
Altundag O, Altundag K, Altundag M. Altundag O, et al. Among authors: altundag m, altundag k. J Clin Oncol. 2004 Aug 1;22(15):3201-2; author reply 3202. doi: 10.1200/JCO.2004.99.020. J Clin Oncol. 2004. PMID: 15284278 No abstract available.
Targeted therapy for targeted patients: trastuzumab in adjuvant treatment of non-small-cell lung cancer.
Altundag K, Altundag O, Morandi P, Gunduz M. Altundag K, et al. Among authors: altundag o. J Clin Oncol. 2005 Feb 20;23(6):1325; author reply 1326-7. doi: 10.1200/JCO.2005.05.192. J Clin Oncol. 2005. PMID: 15718338 No abstract available.
Treatment of Lymph Node-Negative, Early-Stage HER2-Positive Breast Cancer.
Oguz A, Keskin GS, Colak D, Altundag O, Akcali Z. Oguz A, et al. Among authors: altundag o. J Clin Oncol. 2016 Feb 20;34(6):639-40. doi: 10.1200/JCO.2015.63.8411. Epub 2015 Dec 7. J Clin Oncol. 2016. PMID: 26644534 No abstract available.
MRI in breast cancer.
Altundag K, Morandi P, Altundag O. Altundag K, et al. Among authors: altundag o. N Engl J Med. 2004 Nov 18;351(21):2235-6; author reply 2235-6. doi: 10.1056/NEJM200411183512118. N Engl J Med. 2004. PMID: 15548786 No abstract available.
Angiotensin 1-7 and risk for breast cancer recurrence.
Altundag K, Altundag O, Akyurek S, Silay K, Turen S. Altundag K, et al. Among authors: altundag o. Cancer Chemother Pharmacol. 2006 Aug;58(2):283; author reply 284. doi: 10.1007/s00280-005-0153-x. Epub 2005 Nov 22. Cancer Chemother Pharmacol. 2006. PMID: 16328412 No abstract available.
Insulinlike growth factor-1 receptor: predictive factor in breast cancer patients treated with trastuzumab?
Altundag K, Altundag O, Morandi P, Ozcakar B. Altundag K, et al. Among authors: altundag o. Hum Pathol. 2005 Apr;36(4):448-9; author reply 449. doi: 10.1016/j.humpath.2005.02.008. Hum Pathol. 2005. PMID: 15892011 No abstract available.
125 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback